Balanced news tone
News Sentiment
DHR sentiment intelligence
Danaher Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
39 relevant articles
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
+0.6% over one week, +10.7% over four weeks, trend inactive, and near fair-value range.
Danaher's Leica Biosystems to Acquire StatLab Medical Products
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
85/100 classification
One-week reaction
0.6%
Price digesting
Trend fit
Trend inactive
10.7% over four weeks
Fair value
-9.4%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
11
Neutral
25
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
MT Newswires
Direct company coverage
Danaher's Leica Biosystems to Acquire StatLab Medical Products
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 21:58
- Source
- MT Newswires
Stock Titan
Direct company coverage
Lab-products maker StatLab set to join Danaher’s Leica
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 21:25
- Source
- Stock Titan
Zacks
Direct company coverage
Implied Volatility Surging for Danaher Stock Options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 19:39
- Source
- Zacks
Stock Titan
Direct company coverage
[144] DANAHER CORP /DE/ SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Jul 2026 15:15
- Source
- Stock Titan
Zacks
Direct company coverage
Danaher (DHR) Reports Next Week: Wall Street Expects Earnings Growth
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 14 Jul 2026 14:00
- Source
- Zacks
MT Newswires
Direct company coverage
Baird Adjusts Price Target on Danaher to $251 From $245, Maintains Outperform Rating
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 13 Jul 2026 13:54
- Source
- MT Newswires
Seeking Alpha
Direct company coverage
Danaher Is Getting Better, But The Stock Still Isn't Cheap (NYSE:DHR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 21:44
- Source
- Seeking Alpha
24/7 Wall St.
Direct company coverage
Abbott Labs Vs. Danaher: Abbott’s Everyday Products Beat Danaher’s Slumping Biotech Equipment
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 10 Jul 2026 18:18
- Source
- 24/7 Wall St.
Market source
Direct company coverage
Danaher (DHR) Wins CE Mark For Access P Tau217 Assay, Is The Stock A Bargain?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 21:15
- Source
- Market source
simplywall.st
Direct company coverage
Danaher (DHR) Gains Attention On FDA Clearance, Is The Stock Fully Priced?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 05 Jul 2026 07:00
- Source
- simplywall.st
Ad Hoc News
Direct company coverage
Danaher Corp. focuses on life sciences growth as investors watch long-term strategy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Ad Hoc News
simplywall.st
Direct company coverage
Danaher (DHR) Stock Weighs DCF Upside Against Premium P/E After Recent Bounce
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 19:27
- Source
- simplywall.st
Market source
Direct company coverage
Is Danaher (DHR) One of the Best Non-Tech Stocks to Buy According to Analysts?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Jun 2026 07:00
- Source
- Market source
foreignpolicyjournal.com
Direct company coverage
Danaher (NYSE: DHR) Stock price Drops 22% In 2026 As $9.9 Billion Masimo Deal Reshapes The Investment Case
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 Jun 2026 13:32
- Source
- foreignpolicyjournal.com
Market source
Direct company coverage
Danaher (DHR) Stock Is Up, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
Quiver Quantitative
Direct company coverage
Why Danaher (DHR) Stock Rose Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Quiver Quantitative
Market source
Direct company coverage
Danaher (DHR) Stock Weighs Mixed Valuation Signals After Recent Price Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
HSBC Cuts PT on Danaher Corporation (DHR) – Here’s Why
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Why You Might Be Interested In Danaher Corporation (NYSE:DHR) For Its Upcoming Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 22 Jun 2026 07:00
- Source
- simplywall.st
Ad Hoc News
Direct company coverage
Danaher Stock - long-term strategy in life sciences
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jun 2026 07:00
- Source
- Ad Hoc News
Market source
Direct company coverage
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Danaher Closes Masimo Deal Shifting Monitoring Story Inside Diagnostics Platform
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Jun 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Danaher Completes Acquisition of Masimo Corporation
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 10 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Is It Time To Reassess Danaher (DHR) After Its Recent Share Price Weakness?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- Market source
Ad Hoc News
Direct company coverage
Danaher stock (US2358511028): spin-offs reshape the medtech group after latest quarterly numbers
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- Ad Hoc News
Ad Hoc News
Direct company coverage
Danaher stock (US2358511028): Shares decline amid four-day losing streak
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Ad Hoc News
Market source
Direct company coverage
Is Danaher Corporation (DHR) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Market source
Ad Hoc News
Direct company coverage
Danaher stock (US2358511028): Shares slide as institutional holdings shift
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Ad Hoc News
Ad Hoc News
Direct company coverage
Danaher Corp. Stock (US2358511028): Analyst Downgrades and 52-Week Low Test
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 May 2026 07:00
- Source
- Ad Hoc News